SKU: C-1169-5mg
 GSK-2879552 Chemical Formula: C23H28N2O2 Solid Powder
  • Catalog#: C-1169
  • Targets: LSD1
  • Synonym: GSK2879552; GSK-2879552; GSK 2879552
  • Chemical Name/IUPAC:4-((4-((((1R,2S)-2-phenylcyclopropyl)amino)methyl)piperidin-1-yl)methyl)benzoic acid
  • SMILES Code: O=C(O)C1=CC=C(CN2CCC(CN[C@H]3[C@H](C4=CC=CC=C4)C3)CC2)C=C1
    Technical Data
  • Product Name: GSK-2879552
  • Chemical Formula: C23H28N2O2
  • Molecular Weight: 364.48
  • CAS#: 1401966-69-5
  • Appearance: Solid powder
  • Purity: > 99% by HPLC
  • Solubility: Soluble in DMSO
  • Storage: Room temperature for months, or -20ºC for 3 years
    GSK-2879552 is an orally available, irreversible, inhibitor of lysine specific demethylase 1 (LSD1), with potential antineoplastic activity. Upon administration, GSK-2879552 binds to and inhibits LSD1, a demethylase that suppresses the expression of target genes by converting the dimethylated form of lysine at position 4 of histone H3 (H3K4) to mono- and unmethylated H3K4. LSD1 inhibition enhances H3K4 methylation and increases the expression of tumor-suppressor genes. This may lead to an inhibition of cell growth in LSD1-overexpressing tumor cells. LSD1, overexpressed in certain tumor cells, plays a key role in tumor cell growth and survival.